(Q37953862)

English

Temozolomide plus radiotherapy for glioblastoma in a Canadian province: efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Temozolomide plus radiotherapy for glioblastoma in a Canadian province: efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Nadine Lam

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Carole R Chambers

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Journal of Oncology Pharmacy Practice

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

229-238

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Current and future developments in the use of temozolomide for the treatment of brain tumours

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Factors influencing survival in high-grade gliomas

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Long-term survival with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Mechanisms of disease: temozolomide and glioblastoma--look to the future

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Canadian recommendations for the treatment of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Treatment of glioblastoma multiforme with radiotherapy and concomitant and adjuvant temozolomide: translation of randomised controlled trial evidence into routine clinical practice.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Level of evidence in the literature concerning brain tumor resection

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Extent of resection as a prognostic variable in the treatment of gliomas

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.

1 reference

https://api.crossref.org/works/10.1177%2F1078155211426198

21 January 2018

Identifiers

10.1177/1078155211426198

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37953862&oldid=2088630238"